Skip to main content

Find Clinical Trials

Clinical trial condition

ADHD

Explore clinical trials studying ADHD. Study availability and eligibility vary by location and protocol.

395 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

ADHD trial results

Completed

The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children

NCT02642666

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +10 more
Locations: Triumph Center for Early Childhood Education Sacramento, California, United States

View Trial Details

Completed

Cognitive Training in Children With Attention Deficit/ Hyperactivity Disorder (ADHD)

NCT01752530

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Child and Adolescent Mental Health Services Aabenraa Aabenraa, Denmark

Child and Adolescent Mental Health Services Augustenborg Augustenborg, Denmark

Child and Adolescent Mental Health Services Kolding Kolding, Denmark

View Trial Details

Completed

Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

NCT00501293

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Melmed Center Scottsdale, Arizona, United States

Bay Area Research Institute Lafayette, California, United States

Elite Clinical Trials Inc. Wildomar, California, United States

Sarkis Clinical Trials Gainsville, Florida, United States

View all 32 locations

View Trial Details

Completed

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

NCT00499863

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Melmed Center Scottsdale, Arizona, United States

Bay Area Research Institute Lafayette, California, United States

Elite Clinical Trials Inc. Wildomar, California, United States

Sarkis Clinical Trials Gainesville, Florida, United States

View all 32 locations

View Trial Details

Completed

A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )

NCT02059642

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations: Sarkis Clinical Trials Gainesville, Florida, United States

Miami Research South Miami, Florida, United States

Capstone Clinical Research Libertyville, Illinois, United States

Psychiatric Associates Overland Park, Kansas, United States

View all 20 locations

View Trial Details

Completed

Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment

NCT02473419

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Association Between Smoking, Brain Activity, Genes, and ADHD

NCT00915798

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +5 more
Locations: 2500 Red Hill Avenue Santa Ana, California, United States

View Trial Details

Completed

Efficacy of Neuro+ Attention Training

NCT02642055

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Neuropsychiatric Clinic at Carolina Partners in Mental HealthCare Raleigh, North Carolina, United States

View Trial Details

Completed

Behavioral Effects of Obstructive Sleep Apnea in Children

NCT00060723

Conditions: ADHD, Apnea, Attention Deficit Disorder with Hyperactivity, +17 more
Locations: Univerisity of Michigan Health System Ann Arbor, Michigan, United States

View Trial Details

Completed

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

NCT01673594

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +5 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details